Global medical aesthetics company Classis officially announced its strategy to expand into the European market while participating in the International Congress of Aesthetic Plastic Surgery (IMCAS World Congress 2026, hereinafter IMCAS 2026) held in Paris, France.
Classis participated in IMCAS for the first time after its flagship products, Volumer and Shrink Universe (overseas name: Ultraformer MPT), obtained European Medical Device Regulation (CE-MDR) certification in 2025, and has since begun full-scale market expansion with Europe as its key growth axis.
The "Classis Partner Meeting" held on January 28th was attended by approximately 80 European and global channel partners, who shared the company's achievements in CE-MDR certification and its aggressive growth strategy centered on Europe in 2026. Following this, the IMCAS event, held from January 29th to 31st, showcased a portfolio centered around Volumer and Shrink Universe, along with the introduction of the domestically launched home HIFU device "Leaf2Glow."
The 'Classis Europe Customer Summit' held on the same evening brought together approximately 160 leading European medical professionals and VIP customers to share the company's global vision and 2026 growth strategy, while highlighting its technological competitiveness through the presentation of the latest clinical data and treatment protocols.
A Classis representative stated that CE-MDR certification will be a turning point for the company's leap into the European market, and that the company plans to pursue an aggressive European growth strategy by strengthening its partnerships, sales, and marketing infrastructure starting with IMCAS 2026.
- See more related articles
You must be logged in to post a comment.